P-dichlorobenzene (p-DCB) is a pest repellent and air
deodorant that is commonly found in the household and public buildings. Exposure to p-DCB has been suggested to have potential metabolic and endocrine effects. Little is known about its association with endocrine-related female
cancers. In this cross-sectional study, a nationally representative subsample of 4459 women, aged 20 years or older, in the 2003-2016 National Health and Nutrition Examination Survey was analyzed for the association between p-DCB exposure, measured as urinary concentrations of
2,5-dichlorophenol (2,5-DCP), the primary metabolite of p-DCB, and prevalent endocrine-related female
cancers (defined as breast, ovarian, and
uterine cancers) using multivariate logistic regression models, adjusting for potential confounders. Of the study participants, 202 women (weighted prevalence, 4.20%) reported being diagnosed with any of these endocrine-related reproductive
cancers. Women with reproductive
cancers showed a statistically significant increase in urinary 2,5-DCP concentrations (weighted geometric mean, 7.97 vs. 5.84 µg/g
creatinine; p < 0.0001), compared to women without these
cancers. After adjusting for potential confounders, we found that women in the moderate (1.94- < 28.10 µg/g
creatinine) and high level (≥ 28.10 µg/g
creatinine) of 2,5-DCP had significantly increased odds of endocrine-related reproductive
cancers (odds ratio of 1.66 (95% CI: 1.02, 2.71) and 1.89 (1.08, 3.29), respectively), as compared with those in the low exposure group (< 1.94 µg/g
creatinine). This study demonstrates a potential relation between p-DCB exposure and prevalent endocrine-related reproductive
cancers in US women. Prospective and mechanistic studies would further explore these interactions and elucidate the pathogenesis of endocrine-related female
cancers potentially associated with p-DCB exposure.